img

Global Nuclide Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nuclide Drugs Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Nuclide Drugs Market
Global Nuclide Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nuclide Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Nuclide Drugs key companies include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation and Yantai Dongcheng Pharmaceutical, etc. GE Healthcare, Cardinal Health, Curium Pharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Nuclide Drugs were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Nuclide Drugs market and estimated to attract more attentions from industry insiders and investors.
Nuclide Drugs can be divided into Technetium-99, Iodine-123, Iodine-125 and Iodine-131, etc. Technetium-99 is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Nuclide Drugs is widely used in various fields, such as Therapeutic Use and Diagnostic Use, etc. Therapeutic Use provides greatest supports to the Nuclide Drugs industry development. In 2022, global % revenue of Nuclide Drugs went into Therapeutic Use filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Nuclide Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Nuclide Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Segment by Type
Technetium-99
Iodine-123
Iodine-125
Iodine-131
Fluorine-18
Gallium-67
Others

Segment by Application


Therapeutic Use
Diagnostic Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nuclide Drugs introduction, etc. Nuclide Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Nuclide Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclide Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Technetium-99
1.2.3 Iodine-123
1.2.4 Iodine-125
1.2.5 Iodine-131
1.2.6 Fluorine-18
1.2.7 Gallium-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclide Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Therapeutic Use
1.3.3 Diagnostic Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclide Drugs Market Perspective (2018-2029)
2.2 Global Nuclide Drugs Growth Trends by Region
2.2.1 Nuclide Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nuclide Drugs Historic Market Size by Region (2018-2024)
2.2.3 Nuclide Drugs Forecasted Market Size by Region (2024-2029)
2.3 Nuclide Drugs Market Dynamics
2.3.1 Nuclide Drugs Industry Trends
2.3.2 Nuclide Drugs Market Drivers
2.3.3 Nuclide Drugs Market Challenges
2.3.4 Nuclide Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nuclide Drugs by Players
3.1.1 Global Nuclide Drugs Revenue by Players (2018-2024)
3.1.2 Global Nuclide Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Nuclide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nuclide Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Nuclide Drugs Market Concentration Ratio
3.4.1 Global Nuclide Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclide Drugs Revenue in 2022
3.5 Global Key Players of Nuclide Drugs Head office and Area Served
3.6 Global Key Players of Nuclide Drugs, Product and Application
3.7 Global Key Players of Nuclide Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclide Drugs Breakdown Data by Type
4.1 Global Nuclide Drugs Historic Market Size by Type (2018-2024)
4.2 Global Nuclide Drugs Forecasted Market Size by Type (2024-2029)
5 Nuclide Drugs Breakdown Data by Application
5.1 Global Nuclide Drugs Historic Market Size by Application (2018-2024)
5.2 Global Nuclide Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nuclide Drugs Market Size (2018-2029)
6.2 North America Nuclide Drugs Market Size by Type
6.2.1 North America Nuclide Drugs Market Size by Type (2018-2024)
6.2.2 North America Nuclide Drugs Market Size by Type (2024-2029)
6.2.3 North America Nuclide Drugs Market Share by Type (2018-2029)
6.3 North America Nuclide Drugs Market Size by Application
6.3.1 North America Nuclide Drugs Market Size by Application (2018-2024)
6.3.2 North America Nuclide Drugs Market Size by Application (2024-2029)
6.3.3 North America Nuclide Drugs Market Share by Application (2018-2029)
6.4 North America Nuclide Drugs Market Size by Country
6.4.1 North America Nuclide Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Nuclide Drugs Market Size by Country (2018-2024)
6.4.3 North America Nuclide Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Nuclide Drugs Market Size (2018-2029)
7.2 Europe Nuclide Drugs Market Size by Type
7.2.1 Europe Nuclide Drugs Market Size by Type (2018-2024)
7.2.2 Europe Nuclide Drugs Market Size by Type (2024-2029)
7.2.3 Europe Nuclide Drugs Market Share by Type (2018-2029)
7.3 Europe Nuclide Drugs Market Size by Application
7.3.1 Europe Nuclide Drugs Market Size by Application (2018-2024)
7.3.2 Europe Nuclide Drugs Market Size by Application (2024-2029)
7.3.3 Europe Nuclide Drugs Market Share by Application (2018-2029)
7.4 Europe Nuclide Drugs Market Size by Country
7.4.1 Europe Nuclide Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Nuclide Drugs Market Size by Country (2018-2024)
7.4.3 Europe Nuclide Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nuclide Drugs Market Size (2018-2029)
8.2 China Nuclide Drugs Market Size by Type
8.2.1 China Nuclide Drugs Market Size by Type (2018-2024)
8.2.2 China Nuclide Drugs Market Size by Type (2024-2029)
8.2.3 China Nuclide Drugs Market Share by Type (2018-2029)
8.3 China Nuclide Drugs Market Size by Application
8.3.1 China Nuclide Drugs Market Size by Application (2018-2024)
8.3.2 China Nuclide Drugs Market Size by Application (2024-2029)
8.3.3 China Nuclide Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nuclide Drugs Market Size (2018-2029)
9.2 Asia Nuclide Drugs Market Size by Type
9.2.1 Asia Nuclide Drugs Market Size by Type (2018-2024)
9.2.2 Asia Nuclide Drugs Market Size by Type (2024-2029)
9.2.3 Asia Nuclide Drugs Market Share by Type (2018-2029)
9.3 Asia Nuclide Drugs Market Size by Application
9.3.1 Asia Nuclide Drugs Market Size by Application (2018-2024)
9.3.2 Asia Nuclide Drugs Market Size by Application (2024-2029)
9.3.3 Asia Nuclide Drugs Market Share by Application (2018-2029)
9.4 Asia Nuclide Drugs Market Size by Region
9.4.1 Asia Nuclide Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Nuclide Drugs Market Size by Region (2018-2024)
9.4.3 Asia Nuclide Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nuclide Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Nuclide Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Nuclide Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclide Drugs Introduction
11.1.4 GE Healthcare Revenue in Nuclide Drugs Business (2018-2024)
11.1.5 GE Healthcare Recent Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Details
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health Nuclide Drugs Introduction
11.2.4 Cardinal Health Revenue in Nuclide Drugs Business (2018-2024)
11.2.5 Cardinal Health Recent Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Details
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Nuclide Drugs Introduction
11.3.4 Curium Pharma Revenue in Nuclide Drugs Business (2018-2024)
11.3.5 Curium Pharma Recent Developments
11.4 Lantheus Medical Imaging, Inc.
11.4.1 Lantheus Medical Imaging, Inc. Company Details
11.4.2 Lantheus Medical Imaging, Inc. Business Overview
11.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Introduction
11.4.4 Lantheus Medical Imaging, Inc. Revenue in Nuclide Drugs Business (2018-2024)
11.4.5 Lantheus Medical Imaging, Inc. Recent Developments
11.5 Eczacıbaşı Monrol Nuclear Products
11.5.1 Eczacıbaşı Monrol Nuclear Products Company Details
11.5.2 Eczacıbaşı Monrol Nuclear Products Business Overview
11.5.3 Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Introduction
11.5.4 Eczacıbaşı Monrol Nuclear Products Revenue in Nuclide Drugs Business (2018-2024)
11.5.5 Eczacıbaşı Monrol Nuclear Products Recent Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Company Details
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Nuclide Drugs Introduction
11.6.4 Novartis International AG Revenue in Nuclide Drugs Business (2018-2024)
11.6.5 Novartis International AG Recent Developments
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Nuclide Drugs Introduction
11.7.4 Siemens Revenue in Nuclide Drugs Business (2018-2024)
11.7.5 Siemens Recent Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Details
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Nuclide Drugs Introduction
11.8.4 China Isotope & Radiation Revenue in Nuclide Drugs Business (2018-2024)
11.8.5 China Isotope & Radiation Recent Developments
11.9 Yantai Dongcheng Pharmaceutical
11.9.1 Yantai Dongcheng Pharmaceutical Company Details
11.9.2 Yantai Dongcheng Pharmaceutical Business Overview
11.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Introduction
11.9.4 Yantai Dongcheng Pharmaceutical Revenue in Nuclide Drugs Business (2018-2024)
11.9.5 Yantai Dongcheng Pharmaceutical Recent Developments
11.10 Jubilant Life Sciences
11.10.1 Jubilant Life Sciences Company Details
11.10.2 Jubilant Life Sciences Business Overview
11.10.3 Jubilant Life Sciences Nuclide Drugs Introduction
11.10.4 Jubilant Life Sciences Revenue in Nuclide Drugs Business (2018-2024)
11.10.5 Jubilant Life Sciences Recent Developments
11.11 Bracco
11.11.1 Bracco Company Details
11.11.2 Bracco Business Overview
11.11.3 Bracco Nuclide Drugs Introduction
11.11.4 Bracco Revenue in Nuclide Drugs Business (2018-2024)
11.11.5 Bracco Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nuclide Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Technetium-99
Table 3. Key Players of Iodine-123
Table 4. Key Players of Iodine-125
Table 5. Key Players of Iodine-131
Table 6. Key Players of Fluorine-18
Table 7. Key Players of Gallium-67
Table 8. Key Players of Others
Table 9. Global Nuclide Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Nuclide Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 12. Global Nuclide Drugs Market Share by Region (2018-2024)
Table 13. Global Nuclide Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Nuclide Drugs Market Share by Region (2024-2029)
Table 15. Nuclide Drugs Market Trends
Table 16. Nuclide Drugs Market Drivers
Table 17. Nuclide Drugs Market Challenges
Table 18. Nuclide Drugs Market Restraints
Table 19. Global Nuclide Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 20. Global Nuclide Drugs Revenue Share by Players (2018-2024)
Table 21. Global Top Nuclide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
Table 22. Global Nuclide Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 23. Global 5 Largest Players Market Share by Nuclide Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 24. Global Key Players of Nuclide Drugs, Headquarters and Area Served
Table 25. Global Key Players of Nuclide Drugs, Product and Application
Table 26. Global Key Players of Nuclide Drugs, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 29. Global Nuclide Drugs Revenue Market Share by Type (2018-2024)
Table 30. Global Nuclide Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Nuclide Drugs Revenue Market Share by Type (2024-2029)
Table 32. Global Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 33. Global Nuclide Drugs Revenue Share by Application (2018-2024)
Table 34. Global Nuclide Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Nuclide Drugs Revenue Share by Application (2024-2029)
Table 36. North America Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 37. North America Nuclide Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 39. North America Nuclide Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Nuclide Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 42. North America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 44. Europe Nuclide Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 46. Europe Nuclide Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Nuclide Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 49. Europe Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. China Nuclide Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. China Nuclide Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 55. Asia Nuclide Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 57. Asia Nuclide Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Nuclide Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia Nuclide Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Nuclide Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 68. GE Healthcare Company Details
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Nuclide Drugs Product
Table 71. GE Healthcare Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 72. GE Healthcare Recent Developments
Table 73. Cardinal Health Company Details
Table 74. Cardinal Health Business Overview
Table 75. Cardinal Health Nuclide Drugs Product
Table 76. Cardinal Health Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 77. Cardinal Health Recent Developments
Table 78. Curium Pharma Company Details
Table 79. Curium Pharma Business Overview
Table 80. Curium Pharma Nuclide Drugs Product
Table 81. Curium Pharma Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 82. Curium Pharma Recent Developments
Table 83. Lantheus Medical Imaging, Inc. Company Details
Table 84. Lantheus Medical Imaging, Inc. Business Overview
Table 85. Lantheus Medical Imaging, Inc. Nuclide Drugs Product
Table 86. Lantheus Medical Imaging, Inc. Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 87. Lantheus Medical Imaging, Inc. Recent Developments
Table 88. Eczacıbaşı Monrol Nuclear Products Company Details
Table 89. Eczacıbaşı Monrol Nuclear Products Business Overview
Table 90. Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Product
Table 91. Eczacıbaşı Monrol Nuclear Products Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 92. Eczacıbaşı Monrol Nuclear Products Recent Developments
Table 93. Novartis International AG Company Details
Table 94. Novartis International AG Business Overview
Table 95. Novartis International AG Nuclide Drugs Product
Table 96. Novartis International AG Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 97. Novartis International AG Recent Developments
Table 98. Siemens Company Details
Table 99. Siemens Business Overview
Table 100. Siemens Nuclide Drugs Product
Table 101. Siemens Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 102. Siemens Recent Developments
Table 103. China Isotope & Radiation Company Details
Table 104. China Isotope & Radiation Business Overview
Table 105. China Isotope & Radiation Nuclide Drugs Product
Table 106. China Isotope & Radiation Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 107. China Isotope & Radiation Recent Developments
Table 108. Yantai Dongcheng Pharmaceutical Company Details
Table 109. Yantai Dongcheng Pharmaceutical Business Overview
Table 110. Yantai Dongcheng Pharmaceutical Nuclide Drugs Product
Table 111. Yantai Dongcheng Pharmaceutical Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 112. Yantai Dongcheng Pharmaceutical Recent Developments
Table 113. Jubilant Life Sciences Company Details
Table 114. Jubilant Life Sciences Business Overview
Table 115. Jubilant Life Sciences Nuclide Drugs Product
Table 116. Jubilant Life Sciences Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 117. Jubilant Life Sciences Recent Developments
Table 118. Bracco Company Details
Table 119. Bracco Business Overview
Table 120. Bracco Nuclide Drugs Product
Table 121. Bracco Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 122. Bracco Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclide Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Nuclide Drugs Market Share by Type: 2022 VS 2029
Figure 3. Technetium-99 Features
Figure 4. Iodine-123 Features
Figure 5. Iodine-125 Features
Figure 6. Iodine-131 Features
Figure 7. Fluorine-18 Features
Figure 8. Gallium-67 Features
Figure 9. Others Features
Figure 10. Global Nuclide Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Nuclide Drugs Market Share by Application: 2022 VS 2029
Figure 12. Therapeutic Use Case Studies
Figure 13. Diagnostic Use Case Studies
Figure 14. Nuclide Drugs Report Years Considered
Figure 15. Global Nuclide Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Nuclide Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Nuclide Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Nuclide Drugs Market Share by Players in 2022
Figure 19. Global Top Nuclide Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Nuclide Drugs Revenue in 2022
Figure 21. North America Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Nuclide Drugs Market Share by Type (2018-2029)
Figure 23. North America Nuclide Drugs Market Share by Application (2018-2029)
Figure 24. North America Nuclide Drugs Market Share by Country (2018-2029)
Figure 25. United States Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Nuclide Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Nuclide Drugs Market Share by Type (2018-2029)
Figure 29. Europe Nuclide Drugs Market Share by Application (2018-2029)
Figure 30. Europe Nuclide Drugs Market Share by Country (2018-2029)
Figure 31. Germany Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Nuclide Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Nuclide Drugs Market Share by Type (2018-2029)
Figure 39. China Nuclide Drugs Market Share by Application (2018-2029)
Figure 40. Asia Nuclide Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Nuclide Drugs Market Share by Type (2018-2029)
Figure 42. Asia Nuclide Drugs Market Share by Application (2018-2029)
Figure 43. Asia Nuclide Drugs Market Share by Region (2018-2029)
Figure 44. Japan Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Nuclide Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Nuclide Drugs Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Nuclide Drugs Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Nuclide Drugs Market Share by Country (2018-2029)
Figure 54. Brazil Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GE Healthcare Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 61. Cardinal Health Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 62. Curium Pharma Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 63. Lantheus Medical Imaging, Inc. Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 64. Eczacıbaşı Monrol Nuclear Products Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 65. Novartis International AG Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 66. Siemens Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 67. China Isotope & Radiation Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 68. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 69. Jubilant Life Sciences Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 70. Bracco Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries